Skip to main content
Top
Published in: Diabetologia 9/2007

01-09-2007 | Research Letter

Mutations in HHEX are not a common cause of monogenic forms of beta cell dysfunction

Authors: J. A. L. Minton, M. van de Bunt, C. Boustred, K. Hussain, A. T. Hattersley, S. Ellard, A. L. Gloyn

Published in: Diabetologia | Issue 9/2007

Login to get access

Excerpt

Haematopoietically expressed homeobox protein (HEX), a divergent homeobox transcription factor, is encoded by the HHEX gene and is required for organogenesis of the ventral pancreas [1]. Mouse embryos lacking HHEX show a complete failure of ventral pancreatic specification [1] and have deletions of the forebrain, midbrain and rostral hindbrain [2]. HEX functions from very early in embryogenesis (E4.5) through adulthood and is involved in the regulation of genes at multiple developmental states, including mature tissue and cell type [3]. HHEX is expressed before the gene encoding the key pancreatic transcription factor, pancreatic and duodenal homeobox protein 1 (PDX1), and mouse embryos lacking HHEX do not express PDX1 in the ventral pancreas, whereas expression in the dorsal pancreas is unaffected [1]. HEX has also been shown to activate hepatocyte nuclear factor 1α (HNF1α), an important transcription factor not only in beta cell development but also in the regulation of insulin secretion [4]. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Bort R, Martinez-Barbera JP, Beddington RS, Zaret KS (2004) Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131:797–806PubMedCrossRef Bort R, Martinez-Barbera JP, Beddington RS, Zaret KS (2004) Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131:797–806PubMedCrossRef
2.
go back to reference Martinez Barbera JP, Clements M, Thomas P et al (2000) The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127:2433–2445PubMed Martinez Barbera JP, Clements M, Thomas P et al (2000) The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127:2433–2445PubMed
3.
go back to reference Bogue CW, Ganea GR, Sturm E, Ianucci R, Jacobs HC (2000) Hex expression suggests a role in the development and function of organs derived from foregut endoderm. Dev Dyn 219:84–89PubMedCrossRef Bogue CW, Ganea GR, Sturm E, Ianucci R, Jacobs HC (2000) Hex expression suggests a role in the development and function of organs derived from foregut endoderm. Dev Dyn 219:84–89PubMedCrossRef
4.
go back to reference Tanaka H, Yamamoto T, Ban T et al (2005) Hex stimulates the hepatocyte nuclear factor 1α-mediated activation of transcription. Arch Biochem Biophys 442:117–124PubMedCrossRef Tanaka H, Yamamoto T, Ban T et al (2005) Hex stimulates the hepatocyte nuclear factor 1α-mediated activation of transcription. Arch Biochem Biophys 442:117–124PubMedCrossRef
5.
go back to reference Gloyn AL, Ellard S (2006) Defining the genetic aetiology of monogenic diabetes can improve treatment. Expert Opin Pharmacother 7:1759–1767PubMedCrossRef Gloyn AL, Ellard S (2006) Defining the genetic aetiology of monogenic diabetes can improve treatment. Expert Opin Pharmacother 7:1759–1767PubMedCrossRef
6.
go back to reference Pearson ER, Boj SF, Steele AM et al (2007) Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLos Medicine 4:e118PubMedCrossRef Pearson ER, Boj SF, Steele AM et al (2007) Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLos Medicine 4:e118PubMedCrossRef
7.
go back to reference Sellick GS, Barker KT, Stolte-Dijkstra I et al (2004) Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 36:1301–1305PubMedCrossRef Sellick GS, Barker KT, Stolte-Dijkstra I et al (2004) Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 36:1301–1305PubMedCrossRef
8.
go back to reference McCarthy MI (2004) Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. Hum Mol Genet 13:R33–R41PubMedCrossRef McCarthy MI (2004) Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. Hum Mol Genet 13:R33–R41PubMedCrossRef
9.
go back to reference Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885PubMedCrossRef Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885PubMedCrossRef
10.
go back to reference Frayling TM, Lindgren CM, Chevre JC et al (2003) A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity. Diabetes 52:872–881PubMedCrossRef Frayling TM, Lindgren CM, Chevre JC et al (2003) A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity. Diabetes 52:872–881PubMedCrossRef
Metadata
Title
Mutations in HHEX are not a common cause of monogenic forms of beta cell dysfunction
Authors
J. A. L. Minton
M. van de Bunt
C. Boustred
K. Hussain
A. T. Hattersley
S. Ellard
A. L. Gloyn
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0748-3

Other articles of this Issue 9/2007

Diabetologia 9/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine